Protein 1 | Protein 2 | Combine Score |
---|---|---|
C1QC | C1QB | 0.9990000000000001 |
C1QA | C1QB | 0.9990000000000001 |
C1R | C1S | 0.998 |
C1QA | C1QC | 0.997 |
IL6 | CXCL8 | 0.985 |
IL6 | ALB | 0.983 |
LEP | CRP | 0.981 |
C1R | C1QB | 0.977 |
INS | LEP | 0.976 |
ADIPOQ | LEP | 0.975 |
C1R | C1QA | 0.973 |
C1S | C1QB | 0.972 |
C1S | C1QA | 0.971 |
C1S | C1QC | 0.97 |
IL6 | CRP | 0.97 |
C1R | C1QC | 0.968 |
ADIPOQ | INS | 0.9670000000000001 |
INS | ALB | 0.9570000000000001 |
IGHV3-11 | IGLL5 | 0.955 |
ADIPOQ | CRP | 0.9520000000000001 |
C1QA | CRP | 0.95 |
IL6 | INS | 0.9470000000000001 |
ADIPOQ | IL6 | 0.946 |
IL6 | LEP | 0.943 |
C1S | CRP | 0.938 |
C1R | CRP | 0.938 |
IGLL5 | C1QA | 0.9279999999999999 |
ALB | CRP | 0.927 |
INS | CRP | 0.922 |
C1QC | CRP | 0.92 |
IGHV3-11 | C1S | 0.9159999999999999 |
IGHV3-11 | C1R | 0.9159999999999999 |
IGLL5 | C1QB | 0.9129999999999999 |
C1QB | CRP | 0.9109999999999999 |
CXCL8 | CRP | 0.909 |
IGLL5 | C1QC | 0.909 |
IGHV3-11 | C1QA | 0.9 |
C1R | IGLL5 | 0.9 |
IGHV3-11 | C1QC | 0.9 |
IGLL5 | CRP | 0.9 |
IGHV3-11 | C1QB | 0.9 |
IGLL5 | C1S | 0.9 |
IGHV3-11 | CRP | 0.9 |
# | 714 (C1QC) | 712 (C1QA) | 715 (C1R) | 3569 (IL6) | 3952 (LEP) | 3630 (INS) | 9370 (ADIPOQ) | 716 (C1S) | 100423062 (IGLL5) | 213 (ALB) | 713 (C1QB) | 3576 (CXCL8) | 1401 (CRP) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
714 (C1QC) | 1.00 | 1.00 | 1.00 | 0.12 | 0.08 | 0.12 | 0.12 | 1.00 | 0.12 | 0.15 | 1.00 | 0.12 | 0.12 |
712 (C1QA) | 1.00 | 1.00 | 0.86 | 0.67 | 0.52 | 0.70 | 0.67 | 0.96 | 0.52 | 0.55 | 1.00 | 0.61 | 0.54 |
715 (C1R) | 1.00 | 0.86 | 1.00 | 0.57 | 0.40 | 0.61 | 0.60 | 0.86 | 0.43 | 0.56 | 0.86 | 0.50 | 0.63 |
3569 (IL6) | 0.12 | 0.67 | 0.57 | 1.00 | 0.66 | 0.74 | 0.80 | 0.69 | 0.66 | 0.60 | 0.67 | 0.72 | 0.61 |
3952 (LEP) | 0.08 | 0.52 | 0.40 | 0.66 | 1.00 | 0.70 | 0.68 | 0.52 | 0.60 | 0.42 | 0.52 | 0.58 | 0.46 |
3630 (INS) | 0.12 | 0.70 | 0.61 | 0.74 | 0.70 | 1.00 | 0.83 | 0.75 | 0.62 | 0.64 | 0.70 | 0.71 | 0.64 |
9370 (ADIPOQ) | 0.12 | 0.67 | 0.60 | 0.80 | 0.68 | 0.83 | 1.00 | 0.74 | 0.63 | 0.68 | 0.67 | 0.71 | 0.65 |
716 (C1S) | 1.00 | 0.96 | 0.86 | 0.69 | 0.52 | 0.75 | 0.74 | 1.00 | 0.53 | 0.60 | 0.96 | 0.64 | 0.57 |
100423062 (IGLL5) | 0.12 | 0.52 | 0.43 | 0.66 | 0.60 | 0.62 | 0.63 | 0.53 | 1.00 | 0.50 | 0.52 | 0.58 | 0.50 |
213 (ALB) | 0.15 | 0.55 | 0.56 | 0.60 | 0.42 | 0.64 | 0.68 | 0.60 | 0.50 | 1.00 | 0.55 | 0.57 | 0.59 |
713 (C1QB) | 1.00 | 1.00 | 0.86 | 0.67 | 0.52 | 0.70 | 0.67 | 0.96 | 0.52 | 0.55 | 1.00 | 0.61 | 0.54 |
3576 (CXCL8) | 0.12 | 0.61 | 0.50 | 0.72 | 0.58 | 0.71 | 0.71 | 0.64 | 0.58 | 0.57 | 0.61 | 1.00 | 0.57 |
1401 (CRP) | 0.12 | 0.54 | 0.63 | 0.61 | 0.46 | 0.64 | 0.65 | 0.57 | 0.50 | 0.59 | 0.54 | 0.57 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRP | Rat | Plasma | - | 9754 m | 0.5 hours | downregulated | 0.45 | 2-DE | Northern indo-australian plate | Male Sprague-Dawley (SD) | 1 | Male Sprague-Dawley (SD) rats of weight 150 ± 10 g kept at standard conditions | 24067188 |
TF | TF Entrez | Gene | Gene Entrez | Type | PMID | Database |
---|---|---|---|---|---|---|
TBP | 6908 | CRP | 1401 | Repression | 24440874 | TRUSST |
REL | 5966 | CRP | 1401 | Activation | 10075672 | TRUSST |
RELA | 5970 | CRP | 1401 | Activation | 22671145 | TRUSST |
CEBPB | 1051 | CRP | 1401 | Repression | 10669650 | TRUSST |
HNF1A | 6927 | CRP | 1401 | Unknown | 10393213 | TRUSST |
NFKB1 | 4790 | CRP | 1401 | Unknown | 10393213 | TRUSST |
FOS | 2353 | CRP | 1401 | Unknown | 12730302 | TRUSST |
STAT3 | 6774 | CRP | 1401 | Unknown | 10075672 | TRUSST |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT735890 | hsa-miR-1184 | Homo sapiens | CRP | 1401 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
MIRT736816 | hsa-miR-1273g-3p | Homo sapiens | CRP | 1401 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
MIRT743326 | hsa-miR-4252 | Homo sapiens | CRP | 1401 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
MIRT744150 | hsa-miR-4418 | Homo sapiens | CRP | 1401 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
MIRT749667 | hsa-miR-509-3-5p | Homo sapiens | CRP | 1401 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
MIRT749703 | hsa-miR-509-5p | Homo sapiens | CRP | 1401 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
MIRT759268 | hsa-miR-7156-3p | Homo sapiens | CRP | 1401 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 26701625 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
1401 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation | GOTERM_BP_DIRECT |
1401 | GO:2000482 | regulation of interleukin-8 secretion | GOTERM_BP_DIRECT |
1401 | GO:0033265 | acetylcholine receptor binding | GOTERM_MF_DIRECT |
1401 | GO:0005576 | extracellular region | GOTERM_CC_DIRECT |
1401 | GO:0045908 | negative regulation of vasodilation | GOTERM_BP_DIRECT |
1401 | GO:0006953 | acute-phase response | GOTERM_BP_DIRECT |
1401 | GO:0006954 | inflammatory response | GOTERM_BP_DIRECT |
1401 | GO:0032930 | positive regulation of superoxide anion generation | GOTERM_BP_DIRECT |
1401 | GO:0005515 | protein binding | GOTERM_MF_DIRECT |
1401 | GO:0010888 | negative regulation of lipid storage | GOTERM_BP_DIRECT |
1401 | GO:0008228 | opsonization | GOTERM_BP_DIRECT |
1401 | GO:0005509 | calcium ion binding | GOTERM_MF_DIRECT |
1401 | GO:0010628 | positive regulation of gene expression | GOTERM_BP_DIRECT |
1401 | GO:0070062 | extracellular exosome | GOTERM_CC_DIRECT |
1401 | GO:0050830 | defense response to Gram-positive bacterium | GOTERM_BP_DIRECT |
1401 | GO:0046790 | SMAD binding | GOTERM_MF_DIRECT |
1401 | GO:0001849 | phosphatidylserine binding | GOTERM_MF_DIRECT |
1401 | GO:0030169 | benzodiazepine receptor binding | GOTERM_MF_DIRECT |
1401 | GO:0050750 | androgen receptor binding | GOTERM_MF_DIRECT |
1401 | GO:0005615 | extracellular space | GOTERM_CC_DIRECT |
Human Entrez ID | KEGG ID | KEGG Term |
---|
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
CRP | 1401 | Lung Neoplasms | C0024121 | Neoplastic Process | 0.31 | 0.399 | 0.862 | group |
CRP | 1401 | Obesity | C0028754 | Disease or Syndrome | 0.4 | 0.399 | 0.862 | disease |
CRP | 1401 | Arthritis, Collagen-Induced | C0971858 | Experimental Model of Disease | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Diabetes Mellitus, Insulin-Dependent | C0011854 | Disease or Syndrome | 0.39 | 0.399 | 0.862 | disease |
CRP | 1401 | Carditis | C0869523 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Rheumatoid Arthritis | C0003873 | Disease or Syndrome | 0.6 | 0.399 | 0.862 | disease |
CRP | 1401 | Heart Diseases | C0018799 | Disease or Syndrome | 0.37 | 0.399 | 0.862 | group |
CRP | 1401 | Anxiety Disorders | C0003469 | Mental or Behavioral Dysfunction | 0.3 | 0.399 | 0.862 | group |
CRP | 1401 | Metabolic Diseases | C0025517 | Disease or Syndrome | 0.35 | 0.399 | 0.862 | group |
CRP | 1401 | Libman-Sacks Disease | C0242380 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Atherosclerosis | C0004153 | Disease or Syndrome | 0.4 | 0.399 | 0.862 | disease |
CRP | 1401 | Meningitis | C0025289 | Disease or Syndrome | 0.31 | 0.399 | 0.862 | disease |
CRP | 1401 | Pericementitis | C0031051 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Myocardial Ischemia | C0151744 | Disease or Syndrome | 0.4 | 0.399 | 0.862 | disease |
CRP | 1401 | Hyperparathyroidism, Secondary | C0020503 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Left-Sided Heart Failure | C0023212 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Nervous System, Organic Arsenic Poisoning | C0274862 | Injury or Poisoning | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Diabetes, Autoimmune | C0205734 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Arthritis, Adjuvant-Induced | C0003865 | Experimental Model of Disease | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Hypertriglyceridemia | C0020557 | Disease or Syndrome | 0.34 | 0.399 | 0.862 | phenotype |
CRP | 1401 | Leishmaniasis, Visceral | C0023290 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Lupus Erythematosus, Systemic | C0024141 | Disease or Syndrome | 0.4 | 0.399 | 0.862 | disease |
CRP | 1401 | Brittle diabetes | C0342302 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Infection | C3714514 | Pathologic Function | 0.35 | 0.399 | 0.862 | group |
CRP | 1401 | Inflammation | C0021368 | Pathologic Function | 0.4 | 0.399 | 0.862 | phenotype |
CRP | 1401 | Periodontitis | C0031099 | Disease or Syndrome | 0.38 | 0.399 | 0.862 | disease |
CRP | 1401 | Thrombosis | C0040053 | Pathologic Function | 0.31 | 0.399 | 0.862 | phenotype |
CRP | 1401 | Malignant neoplasm of lung | C0242379 | Neoplastic Process | 0.35 | 0.399 | 0.862 | disease |
CRP | 1401 | Hypertensive disease | C0020538 | Disease or Syndrome | 0.6 | 0.399 | 0.862 | group |
CRP | 1401 | Substance Withdrawal Syndrome | C0038587 | Mental or Behavioral Dysfunction | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Kidney Failure, Chronic | C0022661 | Disease or Syndrome | 0.34 | 0.399 | 0.862 | disease |
CRP | 1401 | Pustulosis of Palms and Soles | C0030246 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Pasteurellaceae Infections | C0085397 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | group |
CRP | 1401 | Thrombus | C0087086 | Pathologic Function | 0.3 | 0.399 | 0.862 | phenotype |
CRP | 1401 | Liver carcinoma | C2239176 | Neoplastic Process | 0.4 | 0.399 | 0.862 | disease |
CRP | 1401 | Coronary Arteriosclerosis | C0010054 | Disease or Syndrome | 0.4 | 0.399 | 0.862 | disease |
CRP | 1401 | Congestive heart failure | C0018802 | Disease or Syndrome | 0.38 | 0.399 | 0.862 | disease |
CRP | 1401 | Withdrawal Symptoms | C0087169 | Sign or Symptom | 0.3 | 0.399 | 0.862 | phenotype |
CRP | 1401 | Crohn's disease of large bowel | C0156147 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Leishmaniasis | C0023281 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Myocarditis | C0027059 | Disease or Syndrome | 0.31 | 0.399 | 0.862 | disease |
CRP | 1401 | Pachymeningitis | C0030167 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Nephritis, Tubulointerstitial | C0041349 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Heart Failure, Right-Sided | C0235527 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Arsenic Poisoning, Inorganic | C0274861 | Injury or Poisoning | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Acute Coronary Syndrome | C0948089 | Disease or Syndrome | 0.4 | 0.399 | 0.862 | disease |
CRP | 1401 | Crohn's disease of the ileum | C0267380 | Disease or Syndrome | 0.31 | 0.399 | 0.862 | disease |
CRP | 1401 | Arsenic Encephalopathy | C0751851 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Cardiovascular Diseases | C0007222 | Disease or Syndrome | 0.4 | 0.399 | 0.862 | group |
CRP | 1401 | Malaria | C0024530 | Disease or Syndrome | 0.36 | 0.399 | 0.862 | disease |
CRP | 1401 | Drug Withdrawal Symptoms | C0086189 | Sign or Symptom | 0.3 | 0.399 | 0.862 | phenotype |
CRP | 1401 | IIeocolitis | C0949272 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Atherogenesis | C1563937 | Pathologic Function | 0.3 | 0.399 | 0.862 | phenotype |
CRP | 1401 | Psoriasis | C0033860 | Disease or Syndrome | 0.35 | 0.399 | 0.862 | disease |
CRP | 1401 | Arthritis, Experimental | C0993582 | Experimental Model of Disease | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Heart Decompensation | C1961112 | Pathologic Function | 0.3 | 0.399 | 0.862 | phenotype |
CRP | 1401 | Heart failure | C0018801 | Disease or Syndrome | 0.38 | 0.399 | 0.862 | disease |
CRP | 1401 | Diabetes Mellitus, Ketosis-Prone | C3837958 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Arsenic Poisoning | C0311375 | Injury or Poisoning | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Arsenic Induced Polyneuropathy | C0751852 | Injury or Poisoning | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Coronary Artery Disease | C1956346 | Disease or Syndrome | 0.4 | 0.399 | 0.862 | disease |
CRP | 1401 | Myocardial Failure | C1959583 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Crohn Disease | C0010346 | Disease or Syndrome | 0.4 | 0.399 | 0.862 | disease |
CRP | 1401 | Diabetic Retinopathy | C0011884 | Disease or Syndrome | 0.32 | 0.399 | 0.862 | disease |
CRP | 1401 | Nephritis, Interstitial | C0027707 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Anxiety States, Neurotic | C0376280 | Mental or Behavioral Dysfunction | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Metabolic Syndrome X | C0524620 | Disease or Syndrome | 0.4 | 0.399 | 0.862 | disease |
CRP | 1401 | Regional enteritis | C0678202 | Disease or Syndrome | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Anxiety neurosis (finding) | C1279420 | Mental or Behavioral Dysfunction | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Schizophrenia | C0036341 | Mental or Behavioral Dysfunction | 0.38 | 0.399 | 0.862 | disease |
CRP | 1401 | Unipolar Depression | C0041696 | Mental or Behavioral Dysfunction | 0.3 | 0.399 | 0.862 | disease |
CRP | 1401 | Depressed mood | C0344315 | Finding | 0.3 | 0.399 | 0.862 | phenotype |
CRP | 1401 | Major Depressive Disorder | C1269683 | Mental or Behavioral Dysfunction | 0.34 | 0.399 | 0.862 | disease |